Posted on April 25th, 2012, 9:50 am
MarketWatch (press release) WOBURN, Mass., Apr 25, 2012 (BUSINESS WIRE) -- Sirtex Medical Inc., a leading developer of targeted, innovative liver cancer therapies, announced a 47 percent increase in US dose sales of SIR-Spheres(R) microspheres compared to the same period last ... |